中文名 | 淫羊霍定 A |
英文名 | Epimedin A |
别名 | 朝藿定 朝藿定 A 淫羊藿苷A 淫羊霍定A 淫羊藿定 A 淫羊霍定 A 朝藿定A(标准品) 朝藿定A(淫羊霍定A) EPIMEDIN A 朝藿定A |
英文别名 | Epmedin A Epimedin A EPIMEDIN A TIANFUCHEM Epimedin A 4H-1-Benzopyran-4-one,3-[(6-deoxy-2-O-β-D-glucopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)- 3-{[6-deoxy-2-O-(beta-D-glucopyranosyl)-alpha-L-mannopyranosyl]oxy}-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside (6-Deoxy-3-O-beta-D-glucopyranosyl-alpha-L-Mannopyranosyl)oxy]-7-(beta-D-glucopyranosyloxy)-5-hydroxy-2-(4-Methoxyphenyl)-8-(3-Methyl-2-buten-1-yl)-4H-1-benzopyran-4-one |
CAS | 110623-72-8 |
化学式 | C39H50O20 |
分子量 | 838.8 |
InChI | InChI=1/C39H50O20/c1-14(2)5-10-18-20(54-37-31(50)28(47)25(44)21(12-40)55-37)11-19(42)23-27(46)35(33(57-34(18)23)16-6-8-17(52-4)9-7-16)58-39-36(30(49)24(43)15(3)53-39)59-38-32(51)29(48)26(45)22(13-41)56-38/h5-9,11,15,21-22,24-26,28-32,36-45,47-51H,10,12-13H2,1-4H3/t15-,21+,22+,24-,25+,26+,28-,29-,30+,31+,32+,36+,37+,38-,39-/m0/s1 |
密度 | 1.61±0.1 g/cm3(Predicted) |
熔点 | 197-199 °C(Solv: methanol (67-56-1)) |
沸点 | 1099.8±65.0 °C(Predicted) |
闪点 | 333.188°C |
蒸汽压 | 0mmHg at 25°C |
溶解度 | 甲醇: 62.5毫克/毫升 (74.51毫米; 需要超声波) |
折射率 | 1.69 |
酸度系数 | 5.90±0.40(Predicted) |
存储条件 | 2-8℃ |
外观 | 棕黄色结晶粉末 |
物化性质 | 黄色结晶粉末,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于淫羊藿。 |
MDL号 | MFCD30496681 |
海关编号 | 29329990 |
参考资料 展开查看 | 1. 杨茹 刘聪燕 许婷 等. 5种大孔吸附树脂对淫羊藿总黄酮的吸附特性考察[J]. 中国实验方剂学杂志 2020 v.26(06):121-128. 2. 洪雅丹 张凌风 潘娉娉 等. HPLC法同时测定淫羊藿-骨碎补药对中7种成分[J]. 中成药 2019 041(006):1316-1321. 3. 王英哲 姜大成 容路生 肖井雷 张强 翁丽丽.东北产朝鲜淫羊藿中黄酮类成分的对比分析[J].药物分析杂志 2019 39(11):2034-2040. 4. 刘聪燕 高霞 陈彦 等. 仿生酶解肠溶胶囊提高淫羊藿总黄酮口服生物利用度的可行性研究[J]. 中国医药工业杂志 2016(9期):1158-1164. 5. 李婧,王英哲,刘玉翠,景志贤,闫莉,郭俊杰,姜大成,肖井雷.地理环境因子对朝鲜淫羊藿黄酮类成分空间分布影响的探测分析[J].中国中药杂志,2019,44(24):5368-5374. 6. 张燕. 大孔吸附树脂分离纯化淫羊藿EF5黄酮[J]. 北方药学, 2015, 000(011):11-13. 7. 刘聪燕, 高霞, 黄萌萌,等. 淫羊藿总黄酮仿生酶解肠溶胶囊的制备及评价[J]. 中草药, 2016(20). 8. 刘聪燕, 高霞, 陈彦,等. 淫羊藿总黄酮在骨质疏松大鼠体内的药动学行为[J]. 中成药, 2017, 39(008):1595-1600. 9. 高霞, 刘璇, 陈彦,等. 淫羊藿总黄酮的生物转化过程分析[J]. 中国中药杂志, 2013, 38(23):4079. 10. 高霞, 陈彦, 王莹,等. 糊精湿法制粒对淫羊藿总黄酮酶解的影响[J]. 中成药, 2014, 36(007):1392-1397. 11. 彭静, 马益华, 陈彦,等. 固定化蜗牛酶同时生物转化淫羊藿中4种黄酮苷[J]. 中成药, 2016, 38(9):1984-1990. 12. 吴嫣艳,任会旭,冯友龙,张莉,张妤琳.安神补脑胶囊HPLC指纹图谱与3种成分含量测定方法研究[J].广东药科大学学报,2020,36(06):778-783. 13. 许婷,黄萌萌,李瑞云,杨茹,刘丽芳,陈彦.多基原淫羊藿不同部位质量评价研究[J].中草药,2020,51(01):190-196. 14. 兰海,刘欣妍,余玲,莫诺兰,张燕,郭子右,吴清.大孔树脂纯化淫羊藿中朝藿定与淫羊藿苷工艺研究[J].中草药,2020,51(17):4473-4481. 15. [IF=4.545] Yan-dan Zhou et al."Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway."Biomed Pharmacother. 2019 Jan;109:2309 16. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137 17. [IF=4.36] Kun Shi et al."Epimedii Folium and Curculiginis Rhizoma ameliorate lipopolysaccharides-induced cognitive impairment by regulating the TREM2 signaling pathway."J Ethnopharmacol. 2022 Feb;284:114766 18. [IF=3.757] Congyan Liu et al."Enhanced hydrolysis and antitumor efficacy of Epimedium flavonoids mediated by immobilized snailase on silica."Process Biochem. 2019 Nov;86:80 19. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556 20. [IF=5.34] Dong Shao et al."Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology."PHYTOMEDICINE. 2022 Jul;102:154177 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!